https://news.medxy.ai/unraveling-the-genetic-landscape-of-central-serous-chorioretinopathy-implications-for-pathophysiology-and-precision-medicine/Medxy AIen2026-11-09T10:37:07-08:00Unraveling the Genetic Landscape of Central Serous Chorioretinopathy: Implications for Pathophysiology and Precision Medicine https://news.medxy.ai/long-term-outcomes-of-vascularized-flap-reconstruction-in-skull-base-osteoradionecrosis-following-nasopharyngeal-carcinoma-radiotherapy/Medxy AIen2026-11-09T10:35:37-08:00Long-Term Outcomes of Vascularized Flap Reconstruction in Skull Base Osteoradionecrosis Following Nasopharyngeal Carcinoma Radiotherapy https://news.medxy.ai/sex-differences-in-ventral-hernia-repair-outcomes-a-decade-long-cohort-study-insights/Medxy AIen2026-11-09T10:33:59-08:00Sex Differences in Ventral Hernia Repair Outcomes: A Decade-long Cohort Study Insights https://news.medxy.ai/dissecting-uterine-sarcoma-age-specific-incidence-and-survival-disparities-by-histotype-and-race-in-the-us-2000-2019/Medxy AIen2026-11-09T10:32:21-08:00Dissecting Uterine Sarcoma: Age-Specific Incidence and Survival Disparities by Histotype and Race in the US (2000-2019) https://news.medxy.ai/zh/diabetes-risk-stratification/Medxy AIzh2026-11-09T10:31:04-08:00老年女性2型糖尿病风险分层：BMI联合腰围更精准 https://news.medxy.ai/ja/diabetes-risk-measures/Medxy AIja2026-11-09T10:30:48-08:00BMIと腹囲で高齢女性の2型糖尿病リスクをより精緻に捉える https://news.medxy.ai/unraveling-tumor-heterogeneity-with-imaging-biomarkers-to-predict-response-and-survival-in-hcc-treated-with-tace-ici-mtt/Medxy AIen2026-11-09T10:30:44-08:00Unraveling Tumor Heterogeneity with Imaging Biomarkers to Predict Response and Survival in HCC Treated with TACE-ICI-MTT https://news.medxy.ai/vi/bmi-waist-diabetes-risk/Medxy AIvi2026-11-09T10:30:29-08:00Kết hợp BMI và vòng eo để tinh chỉnh nguy cơ đái tháo đường type 2 ở phụ nữ lớn tuổi https://news.medxy.ai/early-rhythm-control-after-acute-ischemic-stroke-in-atrial-fibrillation-a-comprehensive-clinical-review/Medxy AIen2026-11-09T10:29:03-08:00Early Rhythm Control After Acute Ischemic Stroke in Atrial Fibrillation: A Comprehensive Clinical Review https://news.medxy.ai/inflammatory-changes-in-subcutaneous-fat-after-repeated-bariatric-surgery-insights-into-weight-regain-in-women/Medxy AIen2026-11-09T10:27:16-08:00Inflammatory Changes in Subcutaneous Fat After Repeated Bariatric Surgery: Insights into Weight Regain in Women https://news.medxy.ai/enhancing-exercise-capacity-in-hfpef-patients-through-intravenous-iron-insights-from-the-ironmet-hfpef-trial/Medxy AIen2026-11-09T10:25:49-08:00Enhancing Exercise Capacity in HFpEF Patients Through Intravenous Iron: Insights from the IRONMET-HFpEF Trial https://news.medxy.ai/forearm-flexor-strain-as-a-predictor-of-ulnar-collateral-ligament-surgery-risk-in-mlb-pitchers-a-matched-survival-analysis/Medxy AIen2026-11-09T10:24:20-08:00Forearm Flexor Strain as a Predictor of Ulnar Collateral Ligament Surgery Risk in MLB Pitchers: A Matched Survival Analysis https://news.medxy.ai/ja/economic-evaluation-in-scanning-eye-training-for-hemianopia-after-stroke/Medxy AIja2026-11-09T09:48:01-08:00脳卒中後の半盲に対する視覚訓練とリハビリテーション：SEARCH試験 https://news.medxy.ai/zh/diabetes-care-food-assistance/Medxy AIzh2026-11-09T09:47:40-08:00糖尿病管理中护理协调与食物援助转介：来自社区队列研究的启示 https://news.medxy.ai/vi/economic-evaluation-for-scanning-eye-training-for-hemianopia-after-stroke/Medxy AIvi2026-11-09T09:47:34-08:00Đào tạo và phục hồi chức năng cho tình trạng bán manh sau đột quỵ: Thử nghiệm SEARCH https://news.medxy.ai/ja/diabetes-care-coordination-food-support/Medxy AIja2026-11-09T09:47:20-08:00糖尿病管理におけるケアコーディネーションと食料支援紹介の比較：地域コホート研究からの示唆 https://news.medxy.ai/cost-effectiveness-of-visual-scanning-training-for-post-stroke-hemianopia-insights-from-the-search-trial-and-related-evidence/Medxy AIen2026-11-09T09:47:10-08:00Cost-Effectiveness of Visual Scanning Training for Post-Stroke Hemianopia: Insights from the SEARCH Trial and Related Evidence https://news.medxy.ai/vi/care-coordination-vs-food-support/Medxy AIvi2026-11-09T09:46:59-08:00Điều phối chăm sóc hay hỗ trợ thực phẩm: đâu là lựa chọn hiệu quả hơn trong quản lý đái tháo đường? Phân tích từ một nghiên cứu đoàn hệ dựa vào cộng đồng https://news.medxy.ai/zh/childhood-famine-tooth-loss/Medxy AIzh2026-11-09T09:46:20-08:00童年饥荒与晚年失牙：年龄混杂如何“伪造”关联 https://news.medxy.ai/ja/childhood-famine-tooth-loss-2/Medxy AIja2026-11-09T09:46:01-08:00小児期の飢饉は高齢期の歯の喪失に影響するのか：年齢交絡の役割を解き明かす https://news.medxy.ai/vi/childhood-famine-tooth-loss-elderly/Medxy AIvi2026-11-09T09:45:35-08:00Nạn đói thời thơ ấu và nguy cơ mất răng ở tuổi già: Vai trò của nhiễu do tuổi theo đoàn hệ https://news.medxy.ai/childhood-famine-and-its-impact-on-late-life-tooth-loss-unraveling-the-role-of-age-confounding/Medxy AIen2026-11-09T09:45:00-08:00Childhood Famine and Its Impact on Late-Life Tooth Loss: Unraveling the Role of Age Confounding https://news.medxy.ai/neoadjuvant-immunotherapy-in-dmmr-colon-cancer-a-breakthrough-in-survival-outcomes/Medxy AIen2026-11-09T09:44:24-08:00Neoadjuvant Immunotherapy in dMMR Colon Cancer: A Breakthrough in Survival Outcomes https://news.medxy.ai/zh/dupilumab-for-eosinophilic-esophagitis/Medxy AIzh2026-11-09T09:43:44-08:00度普利尤单抗对儿童嗜酸性粒细胞性食管炎有效性、安全性和机制 https://news.medxy.ai/ja/dupilumab-eosinophilic-esophagitis/Medxy AIja2026-11-09T09:43:19-08:00小児好酸球性食道炎に対するDupilumab：最新臨床エビデンスからみた有効性・安全性・機序的示唆 https://news.medxy.ai/vi/dupilumab-eosinophilic-esophagitis-children/Medxy AIvi2026-11-09T09:42:51-08:00Dupilumab trong viêm thực quản tăng bạch cầu ái toan ở trẻ em: hiệu quả, an toàn và những hiểu biết chuyển dịch từ bằng chứng lâm sàng gần đây https://news.medxy.ai/dupilumab-in-pediatric-eosinophilic-esophagitis-efficacy-safety-and-translational-insights-from-recent-clinical-evidence/Medxy AIen2026-11-09T09:42:27-08:00Dupilumab in Pediatric Eosinophilic Esophagitis: Efficacy, Safety, and Translational Insights from Recent Clinical Evidence https://news.medxy.ai/zh/beyond-hereditary-hemochromatosis/Medxy AIzh2026-11-09T09:41:28-08:00超越遗传性血色病：HFE 基因型相关关节病的临床与病理生理新认识 https://news.medxy.ai/ja/hfe-associated-arthropathy/Medxy AIja2026-11-09T09:41:06-08:00遺伝性ヘモクロマトーシスを超えて考えるHFE遺伝子型関連関節症：臨床的・病態生理学的知見 https://news.medxy.ai/vi/hfe-genotypes-arthropathy-evidence/Medxy AIvi2026-11-09T09:40:45-08:00Kiểu gen HFE và bệnh khớp: những bằng chứng mới vượt ra ngoài haemochromatosis di truyền https://news.medxy.ai/exploring-hfe-genotype-linked-arthropathy-beyond-genetic-haemochromatosis-clinical-and-pathophysiological-insights/Medxy AIen2026-11-09T09:40:27-08:00Exploring HFE Genotype-Linked Arthropathy Beyond Genetic Haemochromatosis: Clinical and Pathophysiological Insights https://news.medxy.ai/zh/donor-derived-dna-trajectories/Medxy AIzh2026-11-09T09:39:44-08:00肾移植后供者来源游离DNA早期轨迹：长期移植物结局的预测新线索 https://news.medxy.ai/ja/donor-derived-dna-long-term-prognosis/Medxy AIja2026-11-09T09:39:25-08:00腎移植後早期のドナー由来セルフリーDNA推移が示す長期予後の予測価値 https://news.medxy.ai/vi/long-term-prognosis-donor-derived-dna/Medxy AIvi2026-11-09T09:39:06-08:00Các diễn biến ban đầu của DNA tự do trong máu có nguồn gốc từ người hiến sau ghép thận có thể dự báo kết quả ghép tạng lâu dài https://news.medxy.ai/early-donor-derived-cell-free-dna-trajectories-as-predictors-of-long-term-kidney-transplant-outcomes/Medxy AIen2026-11-09T09:38:48-08:00Early Donor-Derived Cell-Free DNA Trajectories as Predictors of Long-Term Kidney Transplant Outcomes https://news.medxy.ai/zh/tuberculosis-risk-score-for-psoriasis-biologics/Medxy AIzh2026-11-09T09:38:06-08:00中国银屑病患者生物制剂治疗前高结核风险临床评分的开发与验证 https://news.medxy.ai/ja/tuberculosis-risk-prediction-score/Medxy AIja2026-11-09T09:37:48-08:00中国人乾癬患者の生物学的療法前における結核高リスク予測臨床スコアの開発と検証 https://news.medxy.ai/vi/clinical-tuberculosis-risk-score/Medxy AIvi2026-11-09T09:37:28-08:00Xây dựng và thẩm định thang điểm lâm sàng dự báo nguy cơ lao cao ở bệnh nhân vảy nến Trung Quốc trước điều trị thuốc sinh học https://news.medxy.ai/development-and-validation-of-a-clinical-score-for-predicting-high-tuberculosis-risk-in-chinese-psoriasis-patients-prior-to-biologic-therapy/Medxy AIen2026-11-09T09:37:11-08:00Development and Validation of a Clinical Score for Predicting High Tuberculosis Risk in Chinese Psoriasis Patients Prior to Biologic Therapy https://news.medxy.ai/ja/treatment-choices-%d1%80%d0%b5%d1%81%d0%bfiratory-papillomatosis/Medxy AIja2026-11-09T09:36:58-08:00再発性呼吸器乳頭腫症における治療選択の鍵は何か：患者重視の離散選択実験 https://news.medxy.ai/vi/treatment-preferences/Medxy AIvi2026-11-09T09:36:31-08:00Người bệnh ưu tiên gì khi lựa chọn điều trị sùi nhú đường hô hấp tái phát? Kết quả từ một thí nghiệm lựa chọn rời rạc https://news.medxy.ai/zh/greater-occipital-nerve-decompression/Medxy AIzh2026-11-09T09:36:31-08:00大枕神经减压术中以肌瓣替代脂肪瓣缓冲，可降低再次手术率 https://news.medxy.ai/ja/greater-occipital-nerve-decompression-2/Medxy AIja2026-11-09T09:36:13-08:00大後頭神経減圧術では筋弁による保護が脂肪弁より再手術率を低下させる https://news.medxy.ai/vi/occipital-nerve-flap-reduces-reoperation/Medxy AIvi2026-11-09T09:35:57-08:00Vạt cơ đệm dây thần kinh chẩm lớn giúp giảm tỷ lệ phẫu thuật lại trong giải phóng GON https://news.medxy.ai/muscle-flap-cushioning-over-fat-flap-in-greater-occipital-nerve-decompression-lowers-reoperation-rates/Medxy AIen2026-11-09T09:35:41-08:00Muscle Flap Cushioning Over Fat Flap in Greater Occipital Nerve Decompression Lowers Reoperation Rates https://news.medxy.ai/zh/icu-volume-and-mortality/Medxy AIzh2026-11-09T09:35:03-08:00ICU患者量与住院死亡率：基于日本全国研究的严重程度分层证据 https://news.medxy.ai/ja/icu-mortality-severity/Medxy AIja2026-11-09T09:34:42-08:00重症度でみるICU患者数と院内死亡率の関係：日本全国データからの知見 https://news.medxy.ai/vi/icu-patient-volume-mortality/Medxy AIvi2026-11-09T09:34:20-08:00Khối lượng bệnh nhân ICU và tử vong nội viện: Bằng chứng từ nghiên cứu toàn quốc tại Nhật Bản https://news.medxy.ai/impact-of-icu-patient-volume-stratified-by-severity-on-in-hospital-mortality-insights-from-a-nationwide-japanese-study/Medxy AIen2026-11-09T09:34:03-08:00Impact of ICU Patient Volume Stratified by Severity on In-Hospital Mortality: Insights from a Nationwide Japanese Study https://news.medxy.ai/zh/rural-hospital-resilience/Medxy AIzh2026-11-09T09:33:25-08:00从“海伦妮”看农村医院韧性：数字与基础设施失灵下的灾害应对经验 https://news.medxy.ai/ja/lessons-from-helene/Medxy AIja2026-11-09T09:33:04-08:00Heleneから学ぶ教訓：災害対応における地方病院のレジリエンスをデジタル障害とインフラ障害から強化する https://news.medxy.ai/vi/rural-hospital-resilience-2/Medxy AIvi2026-11-09T09:32:38-08:00Bài học từ Helene: Tăng cường khả năng chống chịu của bệnh viện nông thôn trước sự cố số hóa và hạ tầng trong ứng phó thảm họa https://news.medxy.ai/lessons-from-helene-strengthening-rural-hospital-resilience-amid-digital-and-infrastructure-failures-in-disaster-response/Medxy AIen2026-11-09T09:32:18-08:00Lessons from Helene: Strengthening Rural Hospital Resilience Amid Digital and Infrastructure Failures in Disaster Response https://news.medxy.ai/ja/carpal-tunnel-guidelines/Medxy AIja2026-11-09T09:31:40-08:00手根管症候群に対するAAOS臨床実践ガイドライン：臨床医のための実践的要約 https://news.medxy.ai/vi/aaos-guidelines-carpal-tunnel/Medxy AIvi2026-11-09T09:31:11-08:00Hướng dẫn thực hành lâm sàng của AAOS về hội chứng ống cổ tay: Tóm lược thực tiễn dành cho bác sĩ lâm sàng https://news.medxy.ai/zh/aaos-carpal-tunnel-guidelines/Medxy AIzh2026-11-09T09:30:41-08:00AAOS 腕管综合征临床实践指南：临床医生实用概要 https://news.medxy.ai/vi/vaginal-birth-vs-cesarean-fna-it-risks/Medxy AIvi2026-11-09T09:30:33-08:00Sinh ngả âm đạo hay sinh mổ: nguy cơ chảy máu trong thai kỳ FNAIT nhìn từ một đoàn hệ hồi cứu quốc gia https://news.medxy.ai/aaos-clinical-practice-guidelines-for-carpal-tunnel-syndrome-a-practical-synopsis-for-clinicians/Medxy AIen2026-11-09T09:30:14-08:00AAOS Clinical Practice Guidelines for Carpal Tunnel Syndrome: A Practical Synopsis for Clinicians https://news.medxy.ai/zh/genomic-drivers-childhood-b-all-relapse/Medxy AIzh2026-11-09T09:29:07-08:00揭秘儿童 B-ALL 复发的基因组驱动因素：来自 Children’s Oncology Group 试验的启示 https://news.medxy.ai/ja/pediatric-leukemia-relapse-genomics/Medxy AIja2026-11-09T09:28:49-08:00小児B-ALL再発のゲノム要因を解明：Children’s Oncology Group試験からの知見 https://news.medxy.ai/vi/genomic-factors-b-all-recurrence/Medxy AIvi2026-11-09T09:28:27-08:00Giải mã các yếu tố genom thúc đẩy tái phát trong B-ALL ở trẻ em: Phát hiện từ thử nghiệm của Children’s Oncology Group https://news.medxy.ai/unraveling-genomic-drivers-of-relapse-in-childhood-b-all-insights-from-the-childrens-oncology-group-trial/Medxy AIen2026-11-09T09:28:08-08:00Unraveling Genomic Drivers of Relapse in Childhood B-ALL: Insights from the Children’s Oncology Group Trial https://news.medxy.ai/ja/as-needed-inhaled-steroids-asthma/Medxy AIja2026-11-09T09:27:29-08:00喘息における頓用吸入ステロイドの使いどころとは？—より安全なレスキュー治療に向けたATS新指針 https://news.medxy.ai/vi/as-needed-inhaled-corticosteroids/Medxy AIvi2026-11-09T09:26:54-08:00Khi nào nên dùng corticosteroid dạng hít khi cần trong hen phế quản: Hướng dẫn ATS mới về chiến lược cắt cơn an toàn hơn https://news.medxy.ai/zh/as-needed-asthma-inhalers/Medxy AIzh2026-11-09T09:26:26-08:00哮喘何时应使用按需吸入激素？ATS最新指导让急救方案更安全 https://news.medxy.ai/when-to-use-as-needed-inhaled-steroids-for-asthma-new-ats-guidance-for-safer-reliever-strategies/Medxy AIen2026-11-09T09:26:00-08:00When to Use As-Needed Inhaled Steroids for Asthma: New ATS Guidance for Safer Reliever Strategies https://news.medxy.ai/zh/beta-catenin-liver-cancer-metabolism/Medxy AIzh2026-11-09T09:25:00-08:00β-catenin突变型肝细胞癌的代谢串扰：谷氨酰胺合成酶缺失如何驱动巨噬细胞重编程与肿瘤进展 https://news.medxy.ai/zh/advances-in-dynamic-voice-ct/Medxy AIzh2026-11-09T09:24:56-08:00复杂声门病变评估新进展：动态语音CT在发声障碍中的应用价值 https://news.medxy.ai/ja/hoarseness-evaluation-ct/Medxy AIja2026-11-09T09:24:36-08:00複雑な声門病変に挑む嗄声評価：Dynamic Voice Computed Tomography の役割 https://news.medxy.ai/ja/metabolic-crosstalk-in-liver-cancer/Medxy AIja2026-11-09T09:24:32-08:00β-カテニン変異肝細胞癌における代謝クロストーク：グルタミン合成酵素喪失がマクロファージ再プログラム化と腫瘍進展に及ぼす影響 https://news.medxy.ai/vi/advanced-hoarseness-assessment/Medxy AIvi2026-11-09T09:24:11-08:00Nâng cao đánh giá khàn tiếng: Vai trò của chụp cắt lớp vi tính giọng nói động trong các bệnh lý thanh môn phức tạp https://news.medxy.ai/vi/metabolic-reprogramming-hepatocellular-carcinoma/Medxy AIvi2026-11-09T09:24:06-08:00Tái cắt chuyển hóa trong ung thư biểu mô tế bào gan đột biến β-catenin: Ảnh hưởng của mất glutamine synthetase lên tái lập trình đại thực bào và tiến triển khối u https://news.medxy.ai/advancing-dysphonia-evaluation-the-role-of-dynamic-voice-computed-tomography-in-complex-glottic-pathologies/Medxy AIen2026-11-09T09:23:55-08:00Advancing Dysphonia Evaluation: The Role of Dynamic Voice Computed Tomography in Complex Glottic Pathologies https://news.medxy.ai/zh/weight-loss-surgery-after-medication-treatment-failure/Medxy AIzh2026-11-09T09:23:18-08:00司美格鲁肽/替尔泊肽治疗失败后，作为有效替代方案的减重与代谢改善手术 https://news.medxy.ai/ja/weight-loss-surgery-after-medication-failure/Medxy AIja2026-11-09T09:22:57-08:00セマグルチド／チルゼパチド治療不成功後の有効な次善策としての減量・代謝改善手術 https://news.medxy.ai/vi/bariatric-surgery-after-medication-failure/Medxy AIvi2026-11-09T09:22:35-08:00Phẫu thuật bariatric: lựa chọn cứu vãn hiệu quả sau thất bại với semaglutide hoặc tirzepatide https://news.medxy.ai/zh/plasma-tau-biomarker/Medxy AIzh2026-11-09T09:21:23-08:00血浆 N 端 tau 可作为阿尔茨海默病认知下降与神经退行性变的生物标志物：来自 ADNI 队列的证据 https://news.medxy.ai/zh/vaginal-birth-cesarean-risks/Medxy AIzh2026-11-09T09:21:23-08:00第一胎经阴道分娩后第二胎剖宫产：新生儿风险显著升高——来自 JUMODA 队列的研究发现 https://news.medxy.ai/ja/cesarean-risks-after-vaginal-birth/Medxy AIja2026-11-09T09:21:03-08:00第1子経腟分娩後の第2子帝王切開：新生児リスクが有意に上昇 ― JUMODAコホート研究による知見 https://news.medxy.ai/ja/adni-plasma-tau-biomarker/Medxy AIja2026-11-09T09:21:00-08:00ADNIコホートが示す血漿N末端tau（NT1）の新たな臨床的意義：認知低下と神経変性を映すバイオマーカー https://news.medxy.ai/vi/second-vaginal-birth-cesarean-neonatal-risk/Medxy AIvi2026-11-09T09:20:37-08:00Thai thứ hai sau sinh ngả âm đạo của thai đầu: mổ lấy thai làm tăng nguy cơ sơ sinh theo dữ liệu từ đoàn hệ JUMODA https://news.medxy.ai/increased-neonatal-risks-with-cesarean-delivery-of-second-twin-following-vaginal-birth-of-first-twin-insights-from-the-jumoda-cohort/Medxy AIen2026-11-09T09:20:21-08:00Increased Neonatal Risks with Cesarean Delivery of Second Twin Following Vaginal Birth of First Twin: Insights from the JUMODA Cohort https://news.medxy.ai/vi/plasma-tau-biomarker-alzheimer/Medxy AIvi2026-11-09T09:20:15-08:00Tau đầu N trong huyết tương như một dấu ấn sinh học cho suy giảm nhận thức và thoái hóa thần kinh ở bệnh Alzheimer: Phân tích từ đoàn hệ ADNI https://news.medxy.ai/zh/mri-biomarkers-fatty-liver/Medxy AIzh2026-11-09T09:19:43-08:00MRI 生物标志物在代谢功能障碍相关脂肪性肝病风险分层与疗效监测中的新进展 https://news.medxy.ai/ja/mri-biomarkers-masld/Medxy AIja2026-11-09T09:19:25-08:00代謝機能障害関連脂肪性肝疾患におけるリスク層別化および治療効果モニタリングのためのMRIバイオマーカーに関する新たな進展 https://news.medxy.ai/vi/mri-biomarkers-metabolic-liver-disease/Medxy AIvi2026-11-09T09:19:03-08:00Tiến bộ về dấu ấn sinh học MRI trong phân tầng nguy cơ và theo dõi điều trị bệnh gan nhiễm mỡ liên quan rối loạn chuyển hóa https://news.medxy.ai/advances-in-mri-biomarkers-for-risk-stratification-and-treatment-monitoring-in-metabolic-dysfunction-associated-steatotic-liver-disease/Medxy AIen2026-11-09T09:18:39-08:00Advances in MRI Biomarkers for Risk Stratification and Treatment Monitoring in Metabolic Dysfunction-Associated Steatotic Liver Disease https://news.medxy.ai/zh/delirium-predicts-cognitive-decline/Medxy AIzh2026-11-09T09:17:52-08:00住院期谵妄：初始认知正常成年人长期认知下降的强预测因子 https://news.medxy.ai/ja/delirium-predicts-cognitive-decline-3/Medxy AIja2026-11-09T09:17:33-08:00入院中せん妄は長期的な認知機能低下の強い予測因子：当初認知機能が保たれていた成人での検討 https://news.medxy.ai/vi/delirium-predicts-cognitive-decline-2/Medxy AIvi2026-11-09T09:17:12-08:00Delirium trong thời gian nhập viện: Dự báo mạnh mẽ suy giảm nhận thức dài hạn ở người lớn ban đầu không suy giảm nhận thức https://news.medxy.ai/delirium-during-hospitalization-a-strong-predictor-of-long-term-cognitive-decline-in-initially-cognitively-unimpaired-adults/Medxy AIen2026-11-09T09:16:51-08:00Delirium During Hospitalization: A Strong Predictor of Long-Term Cognitive Decline in Initially Cognitively Unimpaired Adults https://news.medxy.ai/zh/early-pancreatic-biomarkers/Medxy AIzh2026-11-09T09:16:09-08:001 型糖尿病高风险儿童外分泌胰腺生物标志物的早期变化：来自 ENDIA 研究的启示 https://news.medxy.ai/ja/early-pancreatic-biomarkers-3/Medxy AIja2026-11-09T09:15:47-08:001型糖尿病リスク児にみられる外分泌膵バイオマーカーの早期変化：ENDIA研究からの示唆 https://news.medxy.ai/early-exocrine-pancreatic-biomarker-changes-in-children-at-risk-of-type-1-diabetes-insights-from-the-endia-study/Medxy AIen2026-11-09T09:15:06-08:00Early Exocrine Pancreatic Biomarker Changes in Children at Risk of Type 1 Diabetes: Insights from the ENDIA Study https://news.medxy.ai/zh/vutrisiran-heart-benefits/Medxy AIzh2026-11-09T09:14:26-08:00Vutrisiran在转甲状腺素蛋白淀粉样变性心肌病中的持续获益：HELIOS-B开放标签延长期研究启示 https://news.medxy.ai/ja/vutrisiran-cardiomyopathy-benefits/Medxy AIja2026-11-09T09:14:08-08:00トランスサイレチンアミロイドーシス心筋症に対するVutrisiranの持続的ベネフィット：HELIOS-B非盲検延長試験からの知見 https://news.medxy.ai/vi/vutrisiran-amyloid-cardiomyopathy-2/Medxy AIvi2026-11-09T09:13:43-08:00Vutrisiran cho bệnh cơ tim do amyloidosis transthyretin: lợi ích bền vững từ phần mở nhãn HELIOS-B https://news.medxy.ai/sustained-benefits-of-vutrisiran-in-transthyretin-amyloidosis-associated-cardiomyopathy-insights-from-the-helios-b-open-label-extension/Medxy AIen2026-11-09T09:13:25-08:00Sustained Benefits of Vutrisiran in Transthyretin Amyloidosis-Associated Cardiomyopathy: Insights From the HELIOS-B Open-Label Extension https://news.medxy.ai/zh/neurocognition-after-acl-reconstruction/Medxy AIzh2026-11-09T09:12:40-08:00ACL重建后运动员的神经认知改变：不确定条件下决策受影响的启示 https://news.medxy.ai/ja/neurocognition-after-acl-reconstruction-2/Medxy AIja2026-11-09T09:12:15-08:00ACL再建後アスリートにみられる神経認知変化：不確実性下の意思決定への示唆 https://news.medxy.ai/vi/acl-reconstruction-impact-on-neurocognition/Medxy AIvi2026-11-09T09:11:52-08:00Những thay đổi về thần kinh nhận thức ở vận động viên sau phẫu thuật tái tạo dây chằng chéo trước (ACL) https://news.medxy.ai/neurocognitive-alterations-in-athletes-post-acl-reconstruction-implications-for-decision-making-under-uncertainty/Medxy AIen2026-11-09T09:11:31-08:00Neurocognitive Alterations in Athletes Post-ACL Reconstruction: Implications for Decision-Making Under Uncertainty https://news.medxy.ai/zh/real-time-ultrasound-laryngeal-emg/Medxy AIzh2026-11-09T09:10:48-08:00实时超声引导下喉肌电图：基于平面内轨迹方法的可行性研究 https://news.medxy.ai/ja/real-time-ultrasound-guided-laryngeal-emg/Medxy AIja2026-11-09T09:10:21-08:00平面内軌道を用いたリアルタイム超音波ガイド下喉頭筋電図：実現可能性研究 https://news.medxy.ai/vi/real-time-ultrasound-laryngeal-emg-2/Medxy AIvi2026-11-09T09:09:54-08:00Điện cơ thanh quản dưới hướng dẫn siêu âm thời gian thực: Nghiên cứu khả thi với tiếp cận quỹ đạo trong mặt phẳng https://news.medxy.ai/real-time-ultrasound-guided-laryngeal-electromyography-a-feasibility-study-using-an-in-plane-trajectory-approach/Medxy AIen2026-11-09T09:09:37-08:00Real-Time Ultrasound-Guided Laryngeal Electromyography: A Feasibility Study Using an In-Plane Trajectory Approach https://news.medxy.ai/zh/injectable-nanofiber-gel/Medxy AIzh2026-11-09T09:08:59-08:00可注射纳米纤维凝胶：提升骨结合与植入物稳定性的突破 https://news.medxy.ai/ja/injectable-nanofiber-gel-2/Medxy AIja2026-11-09T09:08:33-08:00注射可能ナノファイバーゲル：オッセオインテグレーションとインプラント安定性を高める画期的技術 https://news.medxy.ai/vi/injectable-nanofiber-gel-osseointegration/Medxy AIvi2026-11-09T09:08:11-08:00Gel sợi nano có thể tiêm: Bước tiến mới trong tăng cường tích hợp xương và độ ổn định implant https://news.medxy.ai/injectable-nanofiber-gel-a-breakthrough-in-enhancing-osseointegration-and-implant-stability/Medxy AIen2026-11-09T09:07:50-08:00Injectable Nanofiber Gel: A Breakthrough in Enhancing Osseointegration and Implant Stability https://news.medxy.ai/zh/transcatheter-aortic-valve-replacement-4/Medxy AIzh2026-11-09T09:07:07-08:00中度主动脉瓣狭窄合并高风险特征患者的经导管主动脉瓣置换：管理策略的范式转变 https://news.medxy.ai/ja/transcatheter-aortic-valve-replacement-for-moderate-stenosis/Medxy AIja2026-11-09T09:06:49-08:00リスク高値所見を伴う中等度大動脈弁狭窄症に対する経カテーテル大動脈弁置換術：治療戦略を変える可能性 https://news.medxy.ai/vi/tavr-moderate-aortic-stenosis/Medxy AIvi2026-11-09T09:06:25-08:00TAVR ở bệnh nhân hẹp van động mạch chủ mức độ trung bình có đặc điểm nguy cơ: một bước ngoặt trong điều trị https://news.medxy.ai/transcatheter-aortic-valve-replacement-in-moderate-aortic-stenosis-patients-with-at-risk-features-a-paradigm-shift-in-management/Medxy AIen2026-11-09T09:06:05-08:00Transcatheter Aortic Valve Replacement in Moderate Aortic Stenosis Patients with At-Risk Features: A Paradigm Shift in Management https://news.medxy.ai/zh/early-pregnancy-insulin-effects/Medxy AIzh2026-11-09T08:42:10-08:00妊娠早期胰岛素敏感性与分泌功能对新生儿结局及产后血糖调控的不同影响 https://news.medxy.ai/ja/early-pregnancy-insulin-effects/Medxy AIja2026-11-09T08:41:50-08:00妊娠初期のインスリン感受性と分泌能が新生児転帰と産後血糖調節に及ぼす異なる影響 https://news.medxy.ai/vi/early-pregnancy-insulin-disorders/Medxy AIvi2026-11-09T08:41:31-08:00Kháng insulin sớm và rối loạn tiết insulin trong thai kỳ: tác động khác nhau lên kết cục sơ sinh và điều hòa glucose sau sinh https://news.medxy.ai/zh/ez-pave-trial-insights/Medxy AIzh2026-11-09T08:40:22-08:00ASCVD中他汀-依折麦布联合治疗优于单药降脂吗？——Ez-PAVE试验揭示的启示 https://news.medxy.ai/ja/statin-ezetimibe-combination-therapy/Medxy AIja2026-11-09T08:39:59-08:00ASCVDにおけるスタチン・エゼチミブ併用療法は単剤療法を上回るか：Ez-PAVE試験からの知見 https://news.medxy.ai/vi/93864-2/Medxy AIvi2026-11-09T08:39:37-08:00 https://news.medxy.ai/zh/graft-choice-outcomes/Medxy AIzh2026-11-09T08:38:27-08:00ACL-MCL联合损伤中移植物选择对预后的影响：来自法国多中心登记研究的启示 https://news.medxy.ai/ja/graft-choice-outcomes/Medxy AIja2026-11-09T08:37:56-08:00ACL-MCL複合損傷における移植片選択は転帰にどう影響するか：フランス多施設レジストリ研究からの知見 https://news.medxy.ai/vi/acl-graft-choice-outcomes/Medxy AIvi2026-11-09T08:37:32-08:00Ảnh hưởng của lựa chọn mảnh ghép ACL đến kết cục trong tổn thương phối hợp ACL-MCL: Gợi ý từ một cơ sở đăng ký đa trung tâm của Pháp https://news.medxy.ai/zh/balance-sensory-dysfunction-inph/Medxy AIzh2026-11-09T08:36:27-08:00特发性正常压力脑积水中的平衡受损与感觉功能障碍：来自感觉组织测试的启示 https://news.medxy.ai/ja/93857-2/Medxy AIja2026-11-09T08:36:08-08:00 https://news.medxy.ai/vi/balance-sensory-disorders/Medxy AIvi2026-11-09T08:35:32-08:00Suy giảm thăng bằng và rối loạn cảm giác trong não úng thủy áp lực bình thường vô căn: Góc nhìn từ Bài kiểm tra Tổ chức Cảm giác https://news.medxy.ai/ja/93854-2/Medxy AIja2026-11-09T08:34:24-08:00 https://news.medxy.ai/vi/toothpaste-effects-dentin-radiotherapy/Medxy AIvi2026-11-09T08:33:59-08:00Ảnh hưởng của các công thức kem đánh răng khác nhau lên độ vi cứng bề mặt và hoạt tính phân giải gelatin ở ngà răng khỏe mạnh và ngà răng sau xạ trị: Nghiên cứu in vitro https://news.medxy.ai/zh/pediatric-penicillin-delabeling-guidelines/Medxy AIzh2026-11-08T19:46:07-08:00儿童青霉素过敏去标签新指南：2026年《Pediatrics》关键建议 https://news.medxy.ai/zh/high-intensity-walking-training/Medxy AIzh2026-11-08T09:12:32-08:00高强度步行训练如何促进慢性卒中步行恢复：对侧皮质-网状脊髓束变化的作用 https://news.medxy.ai/ja/enhancing-chronic-stroke-walking-recovery/Medxy AIja2026-11-08T09:12:10-08:00慢性期脳卒中の歩行回復を高めるには：高強度歩行訓練後の対側大脳皮質—網様体—脊髄路変化の役割 https://news.medxy.ai/vi/walking-recovery-stroke-rehabilitation/Medxy AIvi2026-11-08T09:11:43-08:00Phục hồi khả năng đi lại trong đột quỵ mạn tính: vai trò của những thay đổi ở bó vỏ não–lưới–tủy sống bên đối diện tổn thương sau tập luyện vận động cường độ cao https://news.medxy.ai/enhancing-walking-recovery-in-chronic-stroke-the-role-of-contralesional-cortico-reticulospinal-tract-changes-following-high-intensity-locomotor-training/Medxy AIen2026-11-08T09:11:23-08:00Enhancing Walking Recovery in Chronic Stroke: The Role of Contralesional Cortico-Reticulospinal Tract Changes Following High-Intensity Locomotor Training https://news.medxy.ai/zh/ai-vs-clinicians-periodontal-tooth-loss-prediction/Medxy AIzh2026-11-08T09:10:38-08:00AI与临床医生谁更准：10年牙周牙齿脱失预后预测的准确性对比 https://news.medxy.ai/ja/ai-vs-clinicians-periodontal-tooth-loss/Medxy AIja2026-11-08T09:10:20-08:00AIと臨床医、どちらがより正確か：歯周病による歯の喪失に関する10年後の予後予測精度の比較 https://news.medxy.ai/vi/ai-vs-clinicians-periodontal-tooth-loss-prediction-2/Medxy AIvi2026-11-08T09:09:59-08:00AI so với bác sĩ lâm sàng: Độ chính xác tiên lượng mất răng nha chu sau 10 năm https://news.medxy.ai/ai-versus-clinicians-evaluating-accuracy-in-10-year-periodontal-tooth-loss-prognosis/Medxy AIen2026-11-08T09:09:42-08:00AI Versus Clinicians: Evaluating Accuracy in 10-Year Periodontal Tooth Loss Prognosis https://news.medxy.ai/zh/endometrial-ablation-levonorgestrel-intrauterine-system/Medxy AIzh2026-11-08T09:08:58-08:00子宫内膜消融联合左炔诺孕酮宫内系统：降低重度月经过多患者子宫切除率的新证据 https://news.medxy.ai/ja/endometrial-ablation-lng-ius/Medxy AIja2026-11-08T09:08:40-08:00過多月経に対する子宮内膜焼灼術とLNG-IUS併用：MIRA2試験が示す子宮摘出術減少の可能性 https://news.medxy.ai/vi/endometrial-ablation-lng-ius-menorrhagia/Medxy AIvi2026-11-08T09:08:19-08:00Đốt nội mạc tử cung phối hợp LNG-IUS: giảm nhu cầu cắt tử cung ở rong kinh nhiều từ thử nghiệm MIRA2 https://news.medxy.ai/combining-endometrial-ablation-with-levonorgestrel-ius-to-reduce-hysterectomy-in-heavy-menstrual-bleeding-insights-from-the-mira2-trial/Medxy AIen2026-11-08T09:08:02-08:00Combining Endometrial Ablation with Levonorgestrel IUS to Reduce Hysterectomy in Heavy Menstrual Bleeding: Insights from the MIRA2 Trial https://news.medxy.ai/zh/pediatric-antibiotic-stewardship/Medxy AIzh2026-11-08T09:07:23-08:00优化儿科急诊肺炎与鼻窦炎抗生素疗程：一项质量改进的成功实践 https://news.medxy.ai/ja/pediatric-antibiotic-stewardship-for-sinusitis/Medxy AIja2026-11-08T09:07:05-08:00小児救急における肺炎および副鼻腔炎に対する抗菌薬投与期間の最適化：質改善の成功事例 https://news.medxy.ai/vi/shorter-antibiotics-for-children/Medxy AIvi2026-11-08T09:06:42-08:00Rút ngắn thời gian dùng kháng sinh cho viêm phổi và viêm xoang ở trẻ em tại khoa cấp cứu: Thành công từ một chương trình cải tiến chất lượng https://news.medxy.ai/optimizing-antibiotic-duration-for-pediatric-pneumonia-and-sinusitis-in-the-emergency-department-a-quality-improvement-success/Medxy AIen2026-11-08T09:06:25-08:00Optimizing Antibiotic Duration for Pediatric Pneumonia and Sinusitis in the Emergency Department: A Quality Improvement Success https://news.medxy.ai/zh/refractory-psoriatic-arthritis/Medxy AIzh2026-11-08T09:05:43-08:00北欧生物制剂治疗银屑病关节炎患者中难治管理与治疗难治性疾病的患病率及特征 https://news.medxy.ai/ja/treatment-resistant-psa-in-nordic-patients/Medxy AIja2026-11-08T09:05:26-08:00北欧PsA患者における治療困難例と治療抵抗性例の有病率・特徴 https://news.medxy.ai/vi/psoriatic-arthritis-biologic-resistance/Medxy AIvi2026-11-08T09:05:06-08:00Viêm khớp vảy nến khó kiểm soát và kháng trị ở bệnh nhân Bắc Âu điều trị bằng thuốc sinh học https://news.medxy.ai/prevalence-and-profile-of-difficult-to-manage-and-treatment-refractory-psoriatic-arthritis-in-nordic-patients-on-biologic-therapies/Medxy AIen2026-11-08T09:04:48-08:00Prevalence and Profile of Difficult-to-Manage and Treatment-Refractory Psoriatic Arthritis in Nordic Patients on Biologic Therapies https://news.medxy.ai/zh/lung-transplant-support-strategies/Medxy AIzh2026-11-08T09:04:12-08:00肺移植术中支持策略优化：限制性体外循环与基于标准的ECMO对早期神经结局的影响 https://news.medxy.ai/ja/lung-transplant-support-ecmo/Medxy AIja2026-11-08T09:03:57-08:00肺移植術中サポート戦略の最適化：制限的体外循環および基準に基づくECMOが早期神経学的転帰に及ぼす影響 https://news.medxy.ai/vi/lung-transplant-support/Medxy AIvi2026-11-08T09:03:38-08:00Tối ưu hóa hỗ trợ trong mổ khi ghép phổi: Ảnh hưởng của CPB hạn chế so với ECMO dựa trên tiêu chí đối với kết cục thần kinh sớm https://news.medxy.ai/optimizing-intraoperative-support-in-lung-transplantation-impact-of-restrictive-cpb-versus-criteria-based-ecmo-on-early-neurologic-outcomes/Medxy AIen2026-11-08T09:03:21-08:00Optimizing Intraoperative Support in Lung Transplantation: Impact of Restrictive CPB Versus Criteria-Based ECMO on Early Neurologic Outcomes https://news.medxy.ai/zh/dupilumab-improves-growth-bone-health/Medxy AIzh2026-11-08T09:02:40-08:00Dupilumab 促进重症特应性皮炎患儿生长并改善骨健康：来自 3 期试验的研究发现 https://news.medxy.ai/ja/dupilumab-improves-growth-bone-health-in-children/Medxy AIja2026-11-08T09:02:21-08:00デュピルマブは重症アトピー性皮膚炎の小児の成長を促進し、骨の健康を改善する：第3相試験からの知見 https://news.medxy.ai/vi/dupilumab-improves-growth-bone-health-2/Medxy AIvi2026-11-08T09:01:57-08:00Dupilumab giúp cải thiện tăng trưởng và sức khỏe xương ở trẻ em mắc viêm da cơ địa nặng: Kết quả từ thử nghiệm pha 3 https://news.medxy.ai/dupilumab-enhances-growth-and-bone-health-in-pediatric-severe-atopic-dermatitis-insights-from-a-phase-3-trial/Medxy AIen2026-11-08T09:01:38-08:00Dupilumab Enhances Growth and Bone Health in Pediatric Severe Atopic Dermatitis: Insights from a Phase 3 Trial https://news.medxy.ai/zh/beyond-bmi-risk-stratification/Medxy AIzh2026-11-08T09:00:58-08:00超越BMI：DIEP皮瓣乳房重建的风险分层应关注皮下脂肪组织与吸烟史 https://news.medxy.ai/ja/diep-flap-risk-stratification/Medxy AIja2026-11-08T09:00:35-08:00DIEPフラップ乳房再建のリスク層別化を見直す：BMIを超えて重要となる皮下脂肪組織と喫煙歴 https://news.medxy.ai/vi/diep-flap-risk-stratification-2/Medxy AIvi2026-11-08T09:00:06-08:00Tinh chỉnh phân tầng nguy cơ trong tái tạo vú bằng vạt DIEP: Vai trò của mô mỡ dưới da và tiền sử hút thuốc vượt lên trên BMI https://news.medxy.ai/refining-risk-stratification-in-diep-flap-breast-reconstruction-the-role-of-subcutaneous-adipose-tissue-and-smoking-history-beyond-bmi/Medxy AIen2026-11-08T08:59:46-08:00Refining Risk Stratification in DIEP Flap Breast Reconstruction: The Role of Subcutaneous Adipose Tissue and Smoking History Beyond BMI https://news.medxy.ai/zh/sepsis-after-organ-transplantation/Medxy AIzh2026-11-08T08:59:07-08:00腹部实体器官移植受者脓毒症的独特免疫谱与生存获益：一项多中心前瞻性队列研究 https://news.medxy.ai/ja/improved-sepsis-outcomes-transplant-patients/Medxy AIja2026-11-08T08:58:45-08:00腹部固形臓器移植患者の敗血症転帰はなぜ良好なのか――多施設前向きコホート研究が示す特異的免疫プロファイルと生存改善 https://news.medxy.ai/vi/abdominal-transplant-sepsis-immunity-survival/Medxy AIvi2026-11-08T08:58:23-08:00Ghép tạng đặc rắn ổ bụng và sepsis: kiểu hình miễn dịch khác biệt cùng cải thiện sống còn qua nghiên cứu đoàn hệ tiền cứu đa trung tâm https://news.medxy.ai/distinct-immunological-profiles-and-improved-survival-in-sepsis-among-abdominal-solid-organ-transplant-recipients-insights-from-a-multicenter-prospective-cohort-study/Medxy AIen2026-11-08T08:58:03-08:00Distinct Immunological Profiles and Improved Survival in Sepsis among Abdominal Solid Organ Transplant Recipients: Insights from a Multicenter Prospective Cohort Study https://news.medxy.ai/zh/ambient-ai-emergency-documentation/Medxy AIzh2026-11-08T08:57:19-08:00环境式AI与人工文书员对急诊医师文书负担和临床生产力的影响：最新证据综述 https://news.medxy.ai/ja/medical-scribe-ai-review/Medxy AIja2026-11-08T08:57:01-08:00救急医の文書作成負担を減らすのは誰か：medical scribe と ambient AI の最新エビデンスレビュー https://news.medxy.ai/medical-scribe-and-ambient-artificial-intelligence-impact-on-emergency-physician-documentation-burden-and-clinical-productivity-a-contemporary-evidence-review/Medxy AIen2026-11-08T08:56:14-08:00Medical Scribe and Ambient Artificial Intelligence Impact on Emergency Physician Documentation Burden and Clinical Productivity: A Contemporary Evidence Review https://news.medxy.ai/zh/high-risk-chronic-care/Medxy AIzh2026-11-08T08:55:27-08:00高风险患者慢性病管理：通过协同照护减少急性医疗利用与成本 https://news.medxy.ai/ja/chronic-disease-care-high-risk-patients/Medxy AIja2026-11-08T08:55:09-08:00高リスク患者における慢性疾患管理：連携したケアで急性期医療利用と費用を抑える https://news.medxy.ai/vi/chronic-care-management/Medxy AIvi2026-11-08T08:54:45-08:00Quản lý bệnh mạn tính ở bệnh nhân nguy cơ cao: giảm sử dụng chăm sóc cấp tính và chi phí nhờ phối hợp chăm sóc https://news.medxy.ai/chronic-care-management-in-high-risk-patients-reducing-acute-care-utilization-and-costs-through-coordinated-care/Medxy AIen2026-11-08T08:54:26-08:00Chronic Care Management in High-Risk Patients: Reducing Acute Care Utilization and Costs Through Coordinated Care https://news.medxy.ai/zh/activating-cd4-t-cells/Medxy AIzh2026-11-08T08:53:48-08:00激活 CD4+ T 细胞：ALK 阳性 T 细胞淋巴瘤靶向免疫治疗的新前沿 https://news.medxy.ai/ja/cd4-immunotherapy-alk-lymphoma/Medxy AIja2026-11-08T08:53:28-08:00CD4+ T細胞を標的にした新たな免疫療法戦略：ALK陽性T細胞リンパ腫への挑戦 https://news.medxy.ai/vi/cd4-t-cell-immunotherapy-alk-lymphoma/Medxy AIvi2026-11-08T08:53:03-08:00Tế bào T CD4+: Hướng đi mới trong miễn dịch trị liệu nhắm đích cho u lympho tế bào T dương tính với ALK https://news.medxy.ai/harnessing-cd4-t-cells-a-new-frontier-in-targeted-immunotherapy-for-alk-positive-t-cell-lymphoma/Medxy AIen2026-11-08T08:52:43-08:00Harnessing CD4+ T Cells: A New Frontier in Targeted Immunotherapy for ALK-Positive T-Cell Lymphoma https://news.medxy.ai/zh/nsclc-immune-landscape/Medxy AIzh2026-11-08T08:52:04-08:00破解NSCLC免疫图谱：基于致癌基因特异性空间蛋白组学识别预后生态位与治疗靶点 https://news.medxy.ai/ja/nsclc-immune-landscape-2/Medxy AIja2026-11-08T08:51:44-08:00NSCLCの免疫景観を読み解く：オンコジーン別空間プロテオミクスが予後ニッチと治療標的を同定 https://news.medxy.ai/vi/nsclc-spatial-proteomics-immunity/Medxy AIvi2026-11-08T08:51:22-08:00Giải mã bối cảnh miễn dịch trong NSCLC: Spatial proteomics theo từng oncogene xác định các “hốc” tiên lượng và đích điều trị https://news.medxy.ai/decoding-the-immune-landscape-in-nsclc-oncogene-specific-spatial-proteomics-identifies-prognostic-niches-and-therapeutic-targets/Medxy AIen2026-11-08T08:51:03-08:00Decoding the Immune Landscape in NSCLC: Oncogene-Specific Spatial Proteomics Identifies Prognostic Niches and Therapeutic Targets https://news.medxy.ai/bi-allelic-prkcz-loss-of-function-variants-presenting-as-adult-onset-retinitis-pigmentosa-a-case-series-and-functional-characterization/Medxy AIen2026-11-08T08:50:25-08:00Bi-Allelic PRKCZ Loss-of-Function Variants Presenting as Adult-Onset Retinitis Pigmentosa: A Case Series and Functional Characterization https://news.medxy.ai/zh/cavernous-sinus-thrombosis-guidelines/Medxy AIzh2026-11-08T08:49:47-08:00海绵窦血栓形成的早识别与规范处理：如何突破诊断难点并制定治疗策略 https://news.medxy.ai/ja/cavernous-sinus-thrombosis/Medxy AIja2026-11-08T08:49:22-08:00海綿静脈洞血栓症の早期認識と治療：診断の難しさを見極め、最適な治療戦略へ https://news.medxy.ai/vi/cavernous-sinus-thrombosis-2/Medxy AIvi2026-11-08T08:48:56-08:00Nhận diện sớm và quản lý chuẩn hóa tình trạng huyết khối xoang hang: Vượt qua các thách thức trong chẩn đoán và xây dựng chiến lược điều trị https://news.medxy.ai/early-recognition-and-management-of-cavernous-sinus-thrombosis-navigating-diagnostic-challenges-and-therapeutic-strategies/Medxy AIen2026-11-08T08:48:35-08:00Early Recognition and Management of Cavernous Sinus Thrombosis: Navigating Diagnostic Challenges and Therapeutic Strategies https://news.medxy.ai/zh/liver-preservation-techniques/Medxy AIzh2026-11-08T08:47:48-08:00循环死亡后器官捐献肝移植结局优化：机器保存技术的比较评估 https://news.medxy.ai/ja/liver-preservation-techniques-2/Medxy AIja2026-11-08T08:47:28-08:00心停止後臓器提供による肝移植の転帰最適化：機械的保存技術の比較評価 https://news.medxy.ai/vi/optimizing-liver-transplant-outcomes/Medxy AIvi2026-11-08T08:47:02-08:00Tối ưu hóa kết cục trong ghép gan từ hiến tạng sau ngừng tuần hoàn: Đánh giá so sánh các kỹ thuật bảo quản bằng máy https://news.medxy.ai/optimizing-outcomes-in-donation-after-circulatory-death-liver-transplantation-a-comparative-evaluation-of-machine-preservation-techniques/Medxy AIen2026-11-08T08:46:41-08:00Optimizing Outcomes in Donation After Circulatory Death Liver Transplantation: A Comparative Evaluation of Machine Preservation Techniques https://news.medxy.ai/zh/hormone-therapy-cardiovascular-effects/Medxy AIzh2026-11-08T08:46:02-08:00围绝经期口服激素疗法对心血管作用的影响 https://news.medxy.ai/ja/cardiometabolic-status-hormone-therapy-cardiovascular-effects/Medxy AIja2026-11-08T08:45:39-08:00経口閉経期ホルモン療法の心血管作用における心代謝状態の影響 https://news.medxy.ai/vi/hormone-therapy-cardiovascular-effects-cardiometabolic-status/Medxy AIvi2026-11-08T08:45:15-08:00Ảnh hưởng của liệu pháp hormone đường uống trong giai đoạn quanh mãn kinh đối với các kết cục tim mạch https://news.medxy.ai/influence-of-cardiometabolic-status-on-cardiovascular-effects-of-oral-menopausal-hormone-therapy/Medxy AIen2026-11-08T08:44:54-08:00Influence of Cardiometabolic Status on Cardiovascular Effects of Oral Menopausal Hormone Therapy https://news.medxy.ai/zh/hbv-infection-heterogeneity/Medxy AIzh2026-11-08T08:43:56-08:00借助 B-BEST 解读 HBV 感染异质性：来自单细胞病毒-宿主转录组学的新发现 https://news.medxy.ai/ja/b-best-hbv-infection-heterogeneity/Medxy AIja2026-11-08T08:43:33-08:00B-BESTで読み解くHBV感染の不均一性――単一細胞ウイルス—宿主トランスクリプトームが示す新知見 https://news.medxy.ai/vi/decoding-hbv-heterogeneity-b-best/Medxy AIvi2026-11-08T08:43:06-08:00Giải mã tính không đồng nhất của nhiễm HBV bằng B-BEST: Những phát hiện từ transcriptomics đơn bào vi rút–vật chủ https://news.medxy.ai/decoding-hbv-infection-heterogeneity-using-b-best-insights-from-single-cell-viral-host-transcriptomics/Medxy AIen2026-11-08T08:42:46-08:00Decoding HBV Infection Heterogeneity Using B-BEST: Insights from Single-Cell Viral-Host Transcriptomics https://news.medxy.ai/ja/epilepsy-maori-children-new-zealand/Medxy AIja2026-11-08T08:41:45-08:00ニュージーランドにおける異なる民族の小児てんかんの、病因、発作型、症候群、および重症度に関する差異 https://news.medxy.ai/vi/epilepsy-maori-children/Medxy AIvi2026-11-08T08:41:20-08:00Động kinh ở trẻ em New Zealand: khác biệt về căn nguyên, thể bệnh, hội chứng và mức độ nặng giữa trẻ Māori và trẻ không phải Māori-không phải Pasifika https://news.medxy.ai/epilepsy-differences-children/Medxy AIen2026-11-08T08:40:56-08:00Differences in Epilepsy Etiology, Type, Syndrome, and Severity Between Māori and Non-Māori-Non-Pasifika Children With Epilepsy in New Zealand https://news.medxy.ai/zh/adult-onset-type-1-diabetes-subtypes/Medxy AIzh2026-11-08T08:40:04-08:00揭示成人起病1型糖尿病的异质性：临床与代谢亚型为精准诊疗带来新启示 https://news.medxy.ai/ja/adult-onset-type-1-diabetes-subtypes-2/Medxy AIja2026-11-08T08:39:42-08:00成人発症1型糖尿病の多様性を解き明かす：臨床・代謝サブタイプが示す精密医療への新たな示唆 https://news.medxy.ai/vi/adult-onset-t1dm-subtypes/Medxy AIvi2026-11-08T08:39:20-08:00Giải mã sự đa dạng của bệnh tiểu đường loại 1 khởi phát ở người trưởng thành: Những gợi ý mới cho y học chính xác từ các phân nhóm lâm sàng và chuyển hóa https://news.medxy.ai/unraveling-the-heterogeneity-of-adult-onset-type-1-diabetes-clinical-and-metabolic-subtypes-reveal-new-insight-for-precision-care/Medxy AIen2026-11-08T08:38:59-08:00Unraveling the Heterogeneity of Adult-Onset Type 1 Diabetes: Clinical and Metabolic Subtypes Reveal New Insight for Precision Care https://news.medxy.ai/zh/targeting-cardiovascular-inflammation/Medxy AIzh2026-11-08T08:38:14-08:00靶向心血管风险相关炎症：口服 NLRP3 抑制剂 Ruvonoflast 的疗效与安全性 https://news.medxy.ai/ja/inflammation-targeted-cardiovascular-therapy/Medxy AIja2026-11-08T08:37:53-08:00心血管リスクにおける炎症標的治療：経口NLRP3阻害薬Ruvonoflastの有効性と安全性 https://news.medxy.ai/vi/targeting-inflammation-cardiovascular-risk/Medxy AIvi2026-11-08T08:37:29-08:00Nhắm trúng viêm trong nguy cơ tim mạch: Hiệu quả và độ an toàn của thuốc ức chế NLRP3 đường uống Ruvonoflast https://news.medxy.ai/targeting-inflammation-in-cardiovascular-risk-efficacy-and-safety-of-oral-nlrp3-inhibitor-ruvonoflast/Medxy AIen2026-11-08T08:37:10-08:00Targeting Inflammation in Cardiovascular Risk: Efficacy and Safety of Oral NLRP3 Inhibitor Ruvonoflast https://news.medxy.ai/zh/wrestler-metabolic-rate-calibration/Medxy AIzh2026-11-08T08:36:23-08:00能量消耗估算更精准：男性大学摔跤运动员静息代谢率方程的验证与优化 https://news.medxy.ai/ja/energy-expenditure-accuracy/Medxy AIja2026-11-08T08:36:02-08:00エネルギー消費をより正確に捉える：男子大学レスラーにおける安静時代謝率予測式の検証と改良 https://news.medxy.ai/vi/resting-metabolic-rate-validation/Medxy AIvi2026-11-08T08:35:36-08:00Ước tính tiêu hao năng lượng chính xác hơn: Thẩm định và tinh chỉnh các phương trình tỷ lệ chuyển hóa khi nghỉ ngơi ở nam đô vật đại học https://news.medxy.ai/precision-in-energy-expenditure-validating-and-refining-resting-metabolic-rate-equations-for-collegiate-male-wrestlers/Medxy AIen2026-11-08T08:35:17-08:00Precision in Energy Expenditure: Validating and Refining Resting Metabolic Rate Equations for Collegiate Male Wrestlers https://news.medxy.ai/zh/bridging-brain-injury-recovery-knowledge-gap/Medxy AIzh2026-11-08T08:34:34-08:00弥合澳大利亚创伤性脑损伤恢复知识缺口：证据综述及实践启示 https://news.medxy.ai/ja/traumatic-brain-injury-recovery-knowledge-gaps/Medxy AIja2026-11-08T08:34:12-08:00オーストラリアにおける外傷性脳損傷後回復の知識格差をどう埋めるか：エビデンスの統合と実践への示唆 https://news.medxy.ai/vi/brain-injury-recovery-evidence/Medxy AIvi2026-11-08T08:33:34-08:00Thu hẹp khoảng trống kiến thức về hồi phục sau chấn thương sọ não ở người Úc: Tổng hợp bằng chứng và hàm ý thực hành https://news.medxy.ai/bridging-the-knowledge-gaps-in-traumatic-brain-injury-recovery-among-australians-a-synthesis-of-evidence-and-implications-for-practice/Medxy AIen2026-11-08T08:33:12-08:00Bridging the Knowledge Gaps in Traumatic Brain Injury Recovery Among Australians: A Synthesis of Evidence and Implications for Practice https://news.medxy.ai/zh/improving-adult-dental-visits/Medxy AIzh2026-11-08T08:32:04-08:00提升成年人常规牙科就诊：来自RETURN随机对照试验的启示 https://news.medxy.ai/ja/increasing-dental-visits/Medxy AIja2026-11-08T08:31:45-08:00成人の定期歯科受診を高めるには：RETURNランダム化比較試験から得られた知見 https://news.medxy.ai/enhancing-routine-dental-visits-in-adults-insights-from-the-return-randomized-controlled-trial/Medxy AIen2026-11-08T08:31:06-08:00Enhancing Routine Dental Visits in Adults: Insights from the RETURN Randomized Controlled Trial https://news.medxy.ai/zh/perioperative-immunotherapy-bladder-cancer/Medxy AIzh2026-11-08T08:30:27-08:00围手术期度伐利尤单抗联合恩沃利单抗方案为肌层浸润性膀胱癌带来生存获益 https://news.medxy.ai/ja/perioperative-treatment-improves-outcomes/Medxy AIja2026-11-08T08:30:04-08:00筋層浸潤性膀胱癌における周術期デュルバルマブ＋エンホルツマブ ベドチン療法が転帰を改善 https://news.medxy.ai/vi/perioperative-treatment-improves-bladder-cancer-outcomes/Medxy AIvi2026-11-08T08:29:45-08:00Phác đồ Durvalumab kết hợp Envafolimab trong giai đoạn quanh phẫu thuật mang lại lợi ích về sống thêm ở bệnh nhân ung thư bàng quang xâm lấn cơ https://news.medxy.ai/perioperative-durvalumab-and-enfortumab-vedotin-regimens-enhance-outcomes-in-muscle-invasive-bladder-cancer/Medxy AIen2026-11-08T08:29:26-08:00Perioperative Durvalumab and Enfortumab Vedotin Regimens Enhance Outcomes in Muscle-Invasive Bladder Cancer https://news.medxy.ai/zh/submandibular-gland-cancer-neck-dissection/Medxy AIzh2026-11-08T04:21:02-08:00临床无淋巴结转移颌下腺癌是否需要选择性颈清扫术？——对生存获益与手术决策的思考